You are on page 1of 8

Taiwan Consumer Discretionary 25 May 2023

Giant Manufacturing (9921 TT)

Target price: TWD205.00 (from TWD160.00)


Share price (25 May): TWD199.00 | Up/downside: +3.0%

Upgrading: spring may come late


Helen Chien
 Improving inventory digestion in EU since March 2023 (886) 2 8758 6254
helen.chien@daiwacm-cathay.com.tw

 China demand remains strong; US likely needs more time for inventory Jack Wang
(886) 2 8758 6256
 Upgrading to Hold (3) from Underperform (4); new 12M TP of TWD205 jack.wang@daiwacm-cathay.com.tw

What’s new: We hosted Giant’s 1Q23 post-results call on 25 May after it Forecast revisions (%)
posted 1Q23 results (see our flash, 10 May). Giant aims to lower inventory, Year to 31 Dec 23E 24E 25E
Revenue change 0.7 1.6 2.5
and expects it to improve in 2H23 and revert to a healthy level in 1H24. We Net profit change (1.0) 6.5 7.0
upgrade Giant to Hold (3) from Underperform (4), as we believe the worst Core EPS (FD) change (1.8) 5.6 6.2
is likely over on top of low expectations from investors and likely inventory Source: Daiwa forecasts
improvement in 2H23.

What’s the impact: Inventory update. Inventory for mid- to low-end bikes
was 8 months in the US (19% of 1Q23 revenue) and 5 months in the EU
(37% of 1Q23 revenue). Inventory for high-end bikes in the US and EU
markets was 4 months. In the EU, Giant has seen some inventory
improvement since March, and expects levels to revert to 4-5 months in
2H23 for mid- to low-end bikes and further reduce to 2-3 months in 2024. In
the US, the inventory issue was relatively worse on overstocking from
social distancing issues post the pandemic. However, Giant plans to offer
price discounts to clear inventory. In China (19% of 1Q23 revenue), Giant 12-month range 169.50-262.95
Market cap (USDbn) 2.42
sees rising outdoor activities post pandemic, and expects revenue growth 3m avg daily turnover (USDm) 12.07
of 10-20% YoY in 2023, with momentum carried forward to 2024 from the Shares outstanding (m) 375
bike upgrade trend. Major shareholder Founder group (35.0%)
2023 outlook. Though Giant maintains its conservative guidance for 2023
(revenue to decline mid- to high-teens YoY, gross margin of 20-21% and Financial summary (TWD)
Year to 31 Dec 23E 24E 25E
operating margin of 7%), the company sees some upside from e-bike
Revenue (m) 79,795 85,322 91,505
(better product mix) and China revenue. Over 2Q-3Q23, Giant is likely to Operating profit (m) 5,825 6,740 7,412
offer price discounts to clear inventory, which may negatively impact its Net profit (m) 3,653 4,840 5,324
gross margin (vs. 21.9% in 1Q23) in addition to other issues including lower Core EPS (fully-diluted) 8.946 11.855 13.039
EPS change (%) (40.7) 32.5 10.0
utilisation rate. However, Giant aims for 24-25% gross margin in the next 5 Daiwa vs Cons. EPS (%) (11.9) (7.5) (8.7)
years due to rising e-bike revenue, ie, 40-50% of total revenue in the next 3 PER (x) 22.2 16.8 15.3
years, up from 32% in 1Q23, thanks to growing e-bike penetration rates in Dividend yield (%) 2.8 3.7 4.1
DPS 5.6 7.4 8.1
the EU and the US. It guides to maintain its opex to sales ratio of 14% in
PBR (x) 2.0 1.6 1.4
the medium term for brand investment, marketing and R&D. We cut our EV/EBITDA (x) 8.6 7.1 6.0
2023E EPS by 2% on non-op items, but raise our 2024-25E EPS by 6% ROE (%) 10.0 10.9 10.3
from higher revenue and lower profit to minority interests. Source: FactSet, Daiwa forecasts

What we recommend: We upgrade Giant to Hold (3) and raise our TP to


TWD205 (from TWD160), now based on our 1-year forward EPS with
higher target PER of 19x (higher than low-end PER of 17-32x during 2016-
17, which was the down-cycle of the bike sector, and its past-5-year
average PER of 18x) as we believe the worst is likely over and expect to
see some signs of inventory improvement in 2H23. Key upside/downside
risks: faster-/slower-than-expected e-bike penetration in Europe and the
US; lower-/higher-than-expected impact of macro uncertainty on demand.

How we differ: Our 2023-25E EPS are 8-12% below the consensus, as we
are more conservative on Giant’s operating margin.

See important disclosures, including any required research certifications, beginning on page 6
Giant Manufacturing (9921 TT): 25 May 2023

Giant: revisions to revenue and earnings forecasts


2023E 2024E 2025E
(TWDm) New Previous Change New Previous Change New Previous Change
Sales 79,795 79,219 0.7% 85,322 83,997 1.6% 91,505 89,254 2.5%
Gross profit 16,996 16,874 0.7% 18,344 18,059 1.6% 19,765 19,190 3.0%
Gross-profit margin 21.3% 21.3% 0.0pp 21.5% 21.5% 0.0pp 21.6% 21.5% 0.1pp
Operating profit 5,825 5,783 0.7% 6,740 6,636 1.6% 7,412 7,230 2.5%
Operating-profit margin 7.3% 7.3% 0.0pp 7.9% 7.9% 0.0pp 8.1% 8.1% 0.0pp
Net profit 3,653 3,689 -1.0% 4,840 4,547 6.5% 5,324 4,974 7.0%
Net-profit margin 4.6% 4.7% -0.1pp 5.7% 5.4% 0.3pp 5.8% 5.6% 0.2pp
Diluted EPS (TWD) 8.95 9.11 -1.8% 11.85 11.23 5.6% 13.04 12.28 6.2%
Source: Daiwa forecasts

Giant: 1Q23 results review


(TWDm) Giant’s 1Q23 results Daiwa forecast Differ Bloomberg consensus Differ
Revenue 20,119 17,519 14.8% 18,162 10.8%
Gross profit 4,405 3,416 28.9% 3,630 21.4%
Operating profit 1,690 876 92.9% 1,061 59.3%
Profit before tax 1,525 904 68.6% 1,364 11.8%
Net profit 836 586 42.6% 895 -6.6%
Basic EPS (TWD) 2.13 1.49 42.6% 2.35 -9.2%
Margin
Gross margin 21.9% 19.5% 2.4pp 20.0% 1.9pp
Operating margin 8.4% 5.0% 3.4pp 5.8% 2.6pp
Pre-tax margin 7.6% 5.2% 2.4pp 7.5% 0.1pp
Net margin 4.2% 3.3% 0.8pp 4.9% -0.8pp
Sources: Company, Daiwa forecasts, Bloomberg

Giant: quarterly P&L


2023E 2024E 2023E 2024E 2025E
(TWDm) 1Q23 2Q23E 3Q23E 4Q23E 1Q24E 2Q24E 3Q24E 4Q24E
Revenue 20,119 20,831 20,500 18,344 21,000 22,200 22,500 19,622 79,795 85,322 91,505
Gross profit 4,405 4,270 4,305 4,016 4,410 4,773 4,950 4,211 16,996 18,344 19,765
Operating profit 1,690 1,437 1,538 1,160 1,533 1,798 2,025 1,384 5,825 6,740 7,412
Pre-tax profit 1,525 1,360 1,460 1,083 1,580 1,845 2,072 1,431 5,428 6,926 7,598
Net profit 836 982 1,030 804 1,101 1,292 1,455 993 3,653 4,840 5,324
Basic EPS (TWD) 2.13 2.51 2.63 2.05 2.81 3.29 3.71 2.53 9.32 12.35 13.58
Diluted EPS (TWD) 2.07 2.41 2.52 1.97 2.70 3.16 3.56 2.43 8.95 11.85 13.04
Margin
Gross margin 21.9% 20.5% 21.0% 21.9% 21.0% 21.5% 22.0% 21.5% 21.3% 21.5% 21.6%
Operating margin 8.4% 6.9% 7.5% 6.3% 7.3% 8.1% 9.0% 7.1% 7.3% 7.9% 8.1%
Pre-tax margin 7.6% 6.5% 7.1% 5.9% 7.5% 8.3% 9.2% 7.3% 6.8% 8.1% 8.3%
Net margin 4.2% 4.7% 5.0% 4.4% 5.2% 5.8% 6.5% 5.1% 4.6% 5.7% 5.8%
YoY
Revenue -9.6% -8.4% -20.8% -13.3% 4.4% 6.6% 9.8% 7.0% -13.3% 6.9% 7.2%
Gross profit -13.6% -23.8% -25.5% -7.7% 0.1% 11.8% 15.0% 4.9% -18.4% 7.9% 7.7%
Operating profit -27.3% -34.7% -34.9% 13.0% -9.3% 25.1% 31.7% 19.3% -26.4% 15.7% 10.0%
Pre-tax profit -41.3% -43.2% -50.7% 37.6% 3.6% 35.7% 41.9% 32.1% -37.9% 27.6% 9.7%
Net profit -54.1% -45.5% -48.6% 277.5% 31.7% 31.5% 41.2% 23.5% -37.5% 32.5% 10.0%
QoQ
Revenue -5.0% 3.5% -1.6% -10.5% 14.5% 5.7% 1.4% -12.8%
Gross profit 1.3% -3.0% 0.8% -6.7% 9.8% 8.2% 3.7% -14.9%
Operating profit 64.6% -14.9% 7.0% -24.5% 32.1% 17.3% 12.6% -31.6%
Pre-tax profit 93.7% -10.8% 7.4% -25.8% 45.9% 16.8% 12.3% -30.9%
Net profit 292.4% 17.5% 4.9% -21.9% 36.8% 17.3% 12.6% -31.7%
Source: Company, Daiwa forecasts
Giant: revenue breakdown by region Giant: 1-year forward PER band

100% (TWD)
600
80%
8% 8% 8% 6% 8% 50 0
10% 11% 10%
15% 10% 11% 11% 10% 11%
60% 13% 400
17% 19% 20%
23% 21% 22% 21%
21% 17% 30 0
40% 10% 10% 10%
20 0
20% 34% 36% 37% 39% 37% 36% 33% 34% 35%
100
0% 0
2017 2018 2019 2020 2021 2022 2023E 2024E 2025E May-16 May-17 Ma y-18 Ma y-19 May-20 Ma y-21 Ma y-22 May-23

Europe North America China China- non bike Japan Taiwan Others Share Price 13x 18x
23 x 28 x 33 x
Source: Company, Daiwa forecasts Source: Bloomberg, Daiwa forecasts

2
Giant Manufacturing (9921 TT): 25 May 2023

Financial summary
Key assumptions
Year to 31 Dec 2018 2019 2020 2021 2022 2023E 2024E 2025E
Sales to Europe YoY (%) 15.5 8.5 15.3 12.6 9.0 (20.0) 10.0 10.0
Sales to North America YoY (%) 19.5 (3.8) 15.4 14.0 (10.0) (50.0) 10.0 10.0
Sales to Asia YoY (%) (2.6) (0.4) 13.9 20.3 34.0 8.4 6.9 7.5
E-bike shipment YoY (%) 102.0 15.2 7.7 15.6 10.8 (2.3) 20.0 20.0

Profit and loss (TWDm)


Year to 31 Dec 2018 2019 2020 2021 2022 2023E 2024E 2025E
Europe 21,686 23,533 27,136 30,567 33,318 26,655 29,320 32,252
North America 13,855 13,324 15,374 17,530 15,777 7,889 8,677 9,545
Other Revenue 24,698 26,592 27,500 33,743 42,948 45,251 47,324 49,708
Total Revenue 60,239 63,450 70,011 81,840 92,044 79,795 85,322 91,505
Other income 0 0 0 0 0 0 0 0
COGS (47,748) (49,793) (53,842) (62,076) (71,220) (62,798) (66,978) (71,740)
SG&A (7,761) (8,051) (8,371) (10,014) (11,378) (9,974) (10,409) (11,164)
Other op.expenses (827) (874) (940) (1,041) (1,532) (1,197) (1,195) (1,190)
Operating profit 3,904 4,732 6,858 8,709 7,914 5,825 6,740 7,412
Net-interest inc./(exp.) (100) 2 21 68 (101) (521) (14) (14)
Assoc/forex/extraord./others 442 75 (46) (49) 924 124 200 200
Pre-tax profit 4,245 4,810 6,833 8,728 8,738 5,428 6,926 7,598
Tax (1,277) (1,215) (1,657) (2,421) (2,561) (1,628) (1,939) (2,127)
Min. int./pref. div./others (105) (220) (227) (377) (333) (147) (147) (147)
Net profit (reported) 2,864 3,375 4,949 5,930 5,844 3,653 4,840 5,324
Net profit (adjusted) 2,864 3,375 4,949 5,930 5,844 3,653 4,840 5,324
EPS (reported)(TWD) 7.636 8.997 13.195 15.811 15.508 9.317 12.346 13.579
EPS (adjusted)(TWD) 7.636 8.997 13.195 15.811 15.508 9.317 12.346 13.579
EPS (adjusted fully-diluted)(TWD) 7.588 8.955 13.117 15.727 15.078 8.946 11.855 13.039
DPS (TWD) 4.600 4.600 8.000 10.000 9.677 5.590 7.408 8.148
EBIT 3,904 4,732 6,858 8,709 7,914 5,825 6,740 7,412
EBITDA 5,224 6,384 8,628 10,656 10,058 7,606 8,591 9,332

Cash flow (TWDm)


Year to 31 Dec 2018 2019 2020 2021 2022 2023E 2024E 2025E
Profit before tax 4,245 4,810 6,833 8,728 8,738 5,428 6,926 7,598
Depreciation and amortisation 1,320 1,652 1,769 1,946 2,144 1,781 1,850 1,920
Tax paid (1,277) (1,215) (1,657) (2,421) (2,561) (1,628) (1,939) (2,127)
Change in working capital (1,602) (3,375) 4,441 (13,259) (7,816) 23,027 1,642 1,396
Other operational CF items 7 66 12 46 7 0 1 1
Cash flow from operations 2,694 1,937 11,398 (4,960) 512 28,607 8,480 8,787
Capex (2,645) (3,358) (2,417) (2,093) (2,472) (1,604) (1,549) (1,549)
Net (acquisitions)/disposals (2,459) (2,722) 1,195 135 1,634 0 0 0
Other investing CF items (219) (279) (235) 205 207 0 0 0
Cash flow from investing (5,323) (6,359) (1,457) (1,752) (631) (1,604) (1,549) (1,549)
Change in debt 2,043 4,517 (5,934) 8,924 1,276 0 0 0
Net share issues/(repurchases) 0 0 0 0 0 0 0 0
Dividends paid (1,313) (1,725) (1,725) (3,001) (3,751) (3,751) (2,192) (2,904)
Other financing CF items 130 185 1,942 (1,149) 7,084 0 0 0
Cash flow from financing 861 2,976 (5,717) 4,775 4,610 (3,751) (2,192) (2,904)
Forex effect/others 0 0 0 0 0 0 0 0
Change in cash (1,768) (1,446) 4,224 (1,937) 4,491 23,252 4,739 4,334
Free cash flow 49 (1,421) 8,980 (7,053) (1,960) 27,003 6,931 7,238
Source: FactSet, Daiwa forecasts

3
Giant Manufacturing (9921 TT): 25 May 2023

Financial summary continued …


Balance sheet (TWDm)
Year to 31 Dec 2018 2019 2020 2021 2022 2023E 2024E 2025E
Cash & short-term investment 8,946 10,492 13,774 10,932 13,968 37,221 41,960 46,294
Inventory 15,554 16,887 18,195 30,872 41,385 20,221 21,567 23,100
Accounts receivable 14,109 14,835 12,604 15,058 17,038 17,929 22,074 23,847
Other current assets 524 421 826 1,200 825 825 825 825
Total current assets 39,133 42,635 45,399 58,062 73,217 76,196 86,427 94,067
Fixed assets 9,183 10,588 11,965 12,182 13,092 12,431 11,581 10,661
Goodwill & intangibles 210 470 454 562 483 483 483 483
Other non-current assets 4,109 5,337 4,684 6,394 6,743 6,743 6,743 6,743
Total assets 52,635 59,030 62,502 77,199 93,535 95,854 105,234 111,954
Short-term debt 13,642 16,953 10,935 19,697 23,112 23,112 23,112 23,112
Accounts payable 12,428 11,802 15,409 18,328 20,875 20,480 21,099 21,804
Other current liabilities 1,120 1,660 1,693 2,425 3,235 3,235 3,235 3,235
Total current liabilities 27,189 30,415 28,038 40,450 47,223 46,828 47,446 48,151
Long-term debt 1,013 2,218 4,241 3,163 6,148 2,390 2,390 2,390
Other non-current liabilities 2,164 2,933 3,262 3,933 4,264 4,264 4,264 4,264
Total liabilities 30,366 35,566 35,541 47,546 57,635 53,482 54,100 54,805
Share capital 3,751 3,751 3,751 3,751 3,921 3,921 3,921 3,921
Reserves/R.E./others 17,055 18,092 21,423 23,725 29,435 35,907 44,669 50,684
Shareholders' equity 20,806 21,843 25,173 27,476 33,356 39,828 48,589 54,605
Minority interests 1,463 1,621 1,788 2,177 2,544 2,544 2,544 2,544
Total equity & liabilities 52,635 59,030 62,502 77,199 93,535 95,854 105,234 111,954
EV 81,810 84,938 77,827 88,743 92,474 65,463 60,724 56,390
Net debt/(cash) 5,709 8,679 1,402 11,928 15,292 (11,719) (16,458) (20,792)
BVPS (TWD) 55.473 58.238 67.117 73.256 88.516 101.585 123.932 139.276

Key ratios (%)


Year to 31 Dec 2018 2019 2020 2021 2022 2023E 2024E 2025E
Sales (YoY) 9.1 5.3 10.3 16.9 12.5 (13.3) 6.9 7.2
EBITDA (YoY) 24.9 22.2 35.1 23.5 (5.6) (24.4) 12.9 8.6
Operating profit (YoY) 32.3 21.2 44.9 27.0 (9.1) (26.4) 15.7 10.0
Net profit (YoY) 39.4 17.8 46.7 19.8 (1.5) (37.5) 32.5 10.0
Core EPS (fully-diluted) (YoY) 39.1 18.0 46.5 19.9 (4.1) (40.7) 32.5 10.0
Gross-profit margin 20.7 21.5 23.1 24.1 22.6 21.3 21.5 21.6
EBITDA margin 8.7 10.1 12.3 13.0 10.9 9.5 10.1 10.2
Operating-profit margin 6.5 7.5 9.8 10.6 8.6 7.3 7.9 8.1
Net profit margin 4.8 5.3 7.1 7.2 6.3 4.6 5.7 5.8
ROAE 14.2 15.8 21.1 22.5 19.2 10.0 10.9 10.3
ROAA 5.7 6.0 8.1 8.5 6.8 3.9 4.8 4.9
ROCE 11.1 11.9 16.2 18.4 13.5 8.8 9.3 9.3
ROIC 10.2 11.8 17.2 18.0 12.1 10.0 14.9 15.0
Net debt to equity 27.4 39.7 5.6 43.4 45.8 n.a. n.a. n.a.
Effective tax rate 30.1 25.3 24.2 27.7 29.3 30.0 28.0 28.0
Accounts receivable (days) 81.2 83.3 71.5 61.7 63.6 80.0 85.6 91.6
Current ratio (x) 1.4 1.4 1.6 1.4 1.6 1.6 1.8 2.0
Net interest cover (x) 38.9 n.a. n.a. n.a. 78.5 11.2 482.4 530.4
Net dividend payout 60.2 51.1 60.6 63.2 62.4 60.0 60.0 60.0
Free cash flow yield 0.1 n.a. 12.0 n.a. n.a. 36.2 9.3 9.7
Source: FactSet, Daiwa forecasts

Company profile

Founded in 1972 and listed in 1994 on Taiwan’s main board, Giant is the largest bicycle maker in
Taiwan, with an annual capacity of c.5m bicycles. In 2022, Europe accounted for 40% of its revenue,
followed by North America (19%) and China (12%). Around 60% of its 2022 revenue came from OBM
(Giant, Liv, momentum) brands, 30% from OEM/ODM (Trek, Scott and Colnago) brands and 10% from
its light alloy business.

4
Giant Manufacturing (9921 TT): 25 May 2023

ESG analysis
ESG risks
Risks Management Analyst comments
The CEO and Chairperson are not the same individual. Led by the Liu family, there are 11
members on the board. The founder and former Chairman is now a director, with his niece, Mrs.
Executive/board
2 Tu, leading Giant. We view Mrs. Tu's leadership to be strong as she is well recognised by the
quality
former Chairman and the board for her capabilities, and she is one of the few female
chairpersons to lead a Taiwanese company.
G Giant has maintained its dividend payout ratio between 60% and 70% (except for 51% in 2019)
Capital management 2 over the past decade, which we believe to be reasonable considering its global leadership status
and expansion needs.
Related party & Revenue from related-party transactions was 58-62% of total revenue during 2019-21, with sales
2
transaction mostly from its OBM (ASP varies with products/markets). We observed no suspicious activity.
Giant does not yet disclose its CSR progress, but targets to release its ESG report by 2023.
However, as the global OEM/OBM leader in the bicycle industry, we believe product quality and
Product quality &
S 1 safety should be its top priority. We see ongoing R&D expenses and relevant investment in new
safety
models and note that Giant has introduced its "Right Ride" system to assist in customers
seeking suitable bike options.
Giant has developed its Giant production management system that diversifies its capacity
Supply chain globally and utilises production resources fully in order to lower political or regional risk. As Giant
S 1
management has control over its material sourcing, design process and manufacturing/OEM, we believe it has
solid supply chain management capability that allows for better cost control than peers.

Note: Management score represents a company's ability to manage/benefit from certain ESG topics. The scores range from 1 to 3, with 1 being the strongest.
Source: Daiwa

5
Giant Manufacturing (9921 TT): 25 May 2023

Important Disclosures and Disclaimer


This publication is produced by Daiwa Securities Group Inc. and/or its non-U.S. affiliates, and distributed by Daiwa Securities Group Inc. and/or its non-U.S. affiliates, except to the extent expressly
provided herein. This publication and the contents hereof are intended for information purposes only, and may be subject to change without further notice. Any use, disclosure, distribution,
dissemination, copying, printing or reliance on this publication for any other purpose without our prior consent or approval is strictly prohibited. Neither Daiwa Securities Group Inc. nor any of its
respective parent, holding, subsidiaries or affiliates, nor any of its respective directors, officers, servants and employees, represent nor warrant the accuracy or completeness of the information
contained herein or as to the existence of other facts which might be significant, and will not accept any responsibility or liability whatsoever for any use of or reliance upon this publication or any
of the contents hereof. Neither this publication, nor any content hereof, constitute, or are to be construed as, an offer or solicitation of an offer to buy or sell any of the securities or investments
mentioned herein in any country or jurisdiction nor, unless expressly provided, any recommendation or investment opinion or a dvice. Any view, recommendation, opinion or advice expressed in
this publication may not necessarily reflect those of Daiwa Securities Group Inc., and/or its affiliates nor any of its respective directors, officers, servants and employees except where the publication
states otherwise. This research report is not to be relied upon by any person in making any investment decision or otherwise advising with respect to, or dealing in, the securities mentioned, as it
does not take into account the specific investment objectives, financial situation and particular needs of any person.
Daiwa Securities Group Inc., its subsidiaries or affiliates, or its or their respective directors, officers and employees from time to time have trades as principals, or have positions in, or have other
interests in the securities of the company under research including market making activities, derivatives in respect of such securities or may have also performed investment banking and other
services for the issuer of such securities. Daiwa Securities Group Inc., its subsidiaries or affiliates do and seek to do business with the company(s) covered in this research report. Therefore,
investors should be aware that a conflict of interest may exist. The following are additional disclosures.
Ownership of Securities
For “Ownership of Securities” information, please visit BlueMatrix disclosure link at https://daiwa3.bluematrix.com/sellside/Disclosures.action.
Investment Banking Relationship
For “Investment Banking Relationship”, please visit BlueMatrix disclosure link at https://daiwa3.bluematrix.com/sellside/Disclosures.action.
Daiwa Securities Co. Ltd. and Daiwa Securities Group Inc.
Daiwa Securities Co. Ltd. is a subsidiary of Daiwa Securities Group Inc.
Investment Banking Relationship
Within the preceding 12 months, the subsidiaries and/or affiliates of Daiwa Securities Group Inc. * has lead-managed public offerings and/or secondary offerings of the equities or relevant securities
of the following companies: Huafang Group Inc (3611 HK), Gaush Meditech Ltd (2407 HK) and AustAsia Group Ltd (2425 HK).
*Subsidiaries of Daiwa Securities Group Inc. for the purposes of this section shall mean any one or more of: Daiwa Capital Markets Hong Kong Limited (大和資本市場香港有限公司), Daiwa Capital
Markets Singapore Limited, Daiwa Capital Markets Australia Limited, Daiwa Capital Markets India Private Limited, Daiwa-Cathay Capital Markets Co., Ltd., Daiwa Securities Capital Markets Korea
Co., Ltd.
Within the last 12 months, the subsidiaries and/or affiliates of Daiwa Securities Group Inc. * has received compensation for investment banking services from Malayan Banking Bhd (MAY MK),
Lotte Rental Co Ltd (089860 KS), SCGM bhd (SCGM MK) and DL E&C Co. Ltd (375500 KS).
Hong Kong
This research is distributed in Hong Kong by Daiwa Capital Markets Hong Kong Limited (大和資本市場香港有限公司) (“DHK”) which is regulated by the Hong Kong Securities and Futures
Commission. Recipients of this research in Hong Kong may contact DHK in respect of any matter arising from or in connection with this research.
Investment Banking Relationship
Within the preceding 12 months, Daiwa Capital Markets Hong Kong Limited has lead-managed public offerings and/or secondary offerings of the equities or relevant securities of the following
companies: Huafang Group Inc (3611 HK), Gaush Meditech Ltd (2407 HK) and AustAsia Group Ltd (2425 HK).
Relevant Relationship (DHK)
DHK may from time to time have an individual employed by or associated with it serves as an officer of any of the companies under its research coverage.

Singapore
This research is distributed in Singapore by Daiwa Capital Markets Singapore Limited and it may only be distributed in Singapore to accredited investors, expert investors and institutional investors
as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to ti me. By virtue of distribution to these category of investors, Daiwa
Capital Markets Singapore Limited and its representatives are not required to comply with Section 36 of the Financial Advisers Act (Chapter 110) (Section 36 relates to disclosure of Daiwa Capital
Markets Singapore Limited’s interest and/or its representative’s interest in securities). Recipients of this research in Singapore may contact Daiwa Capital Markets Singapore Limited in respect of
any matter arising from or in connection with the research.
Australia
This research is distributed in Australia by Daiwa Capital Markets Australia Limited and it may only be distributed in Australia to wholesale investors within the meaning of the Corporations Act.
Recipients of this research in Australia may contact Daiwa Capital Markets Stockbroking Limited in respect of any matter arising from or in connection with the research.
India
This research is distributed in India to Institutional Clients only by Daiwa Capital Markets India Private Limited (Daiwa India) which is an intermediary registered with Securities & Exchange Board
of India as a Stock Broker, Merchant Bank and Research Analyst. Daiwa India, its Research Analyst and their family members and its associates do not have any financial interest save as disclosed
or other undisclosed material conflict of interest in the securities or derivatives of any companies under coverage. The research analyst who prepared this report have no financial interest in
securities of the issuers covered in the report, has not served (nor any members of their household) as officer, employee, director or advisory board member of the issuer(s) covered in the report,
and are not aware of any relevant material conflict of interest involving the analyst or DCMI, and did not receive any compensation from the issuer during the past 12 months. Daiwa India and its
associates, may have received compensation for any products other than Investment Banking (as disclosed)or brokerage services from the subject company in this report or from any third party
during the past 12 months. Daiwa India and its associates may have debt holdings in the subject company. For information on ownership of equity, please visit BlueMatrix disclosure Link at
https://daiwa3.bluematrix.com/sellside/Disclosures.action.
There is no material disciplinary action against Daiwa India by any regulatory authority impacting equity research analysis activities as of the date of this report.
Associates of Daiwa India, registered with Indian regulators, include Daiwa Capital Markets Singapore Limited and Daiwa Portfolio Advisory (India) Private Limited and Associates of Daiwa India
having office in India but not registered with any Indian regulators include Daiwa Corporate Advisory India Private Limited.
Taiwan
This research is solely for reference and not intended to provide tailored investment recommendations. This research is distributed in Taiwan by Daiwa-Cathay Capital Markets Co., Ltd. and it
may only be distributed in Taiwan to specific customers who have signed recommendation contracts with Daiwa-Cathay Capital Markets Co., Ltd. and non-customers including (i) professional
institutional investors, (ii) TWSE or TPEx listed companies, upstream and downstream vendors, and specialists that offer or seek advice, and (iii) potential customers with an actual need for
business development in accordance with the Operational Regulations Governing Securities Firms Recommending Trades in Securities to Customers. Recipients of this research including non-
customer recipients of this research shall not provide it to others or engage in any activities in connection with this research which may involve conflicts of interests. Neither Daiwa-Cathay Capital
Markets Co., Ltd. nor its personnel who writes or reviews the research report has any conflict of interest in this research. Since Daiwa-Cathay Capital Markets Co., Ltd. does not operate brokerage
trading business in foreign markets, this research is prepared on a “without recommendation” to any foreign securities basis and Daiwa-Cathay Capital Markets Co., Ltd. does not accept
orders from customers to trade in such foreign securities. Recipients of this research shall carefully judge their own investment risk and take full responsibility for the results of any resulting
investments in the companies and/or sectors featured in this research. Without the prior written permission of Daiwa-Cathay Capital Markets Co., Ltd., recipients of this research are prohibited
from disclosing the research to the media, reprinting the research, or quoting from the research to other parties. Recipients of this research in Taiwan may contact Daiwa-Cathay Capital Markets
Co., Ltd. in respect of any matter arising from or in connection with the research.
Philippines
This research is distributed in the Philippines by DBP-Daiwa Capital Markets Philippines, Inc. which is regulated by the Philippines Securities and Exchange Commission and the Philippines Stock
Exchange, Inc. Recipients of this research in the Philippines may contact DBP-Daiwa Capital Markets Philippines, Inc. in respect of any matter arising from or in connection with the research. DBP-
Daiwa Capital Markets Philippines, Inc. recommends that investors independently assess, with a professional advisor, the specific financial risks as well as the legal, regulatory, tax, accounting,
and other consequences of a proposed transaction. DBP-Daiwa Capital Markets Philippines, Inc. may have positions or may be materially interested in the securities in any of the markets mentioned
in the publication or may have performed other services for the issuers of such securities.
For relevant securities and trading rules please visit SEC and PSE links at http://www.sec.gov.ph and http://www.pse.com.ph/ respectively.
Thailand
This research is distributed to only institutional investors in Thailand. This report is provided to you for informational purposes only. Information contained herein is not intended to be, and shall not
be construed as, an offer or an invitation for subscription or purchase of securities in Thailand. This document has not been and will not be registered with, or approved by, the Office of the
Securities and Exchange Commission of Thailand. As neither Daiwa Securities Group Inc. nor any of its subsidiaries or affiliates, nor any of the foregoing entities’ respective directors, officers,
servants and employees are licensed to carry on any securities business in Thailand, this document is intended to be read by the addressee who is an institutional investor only and may not be
circulated or distributed, whether directly or indirectly, to the public or any members of the public in Thailand, unless to the extent permitted by applicable laws and regulations.
This report is prepared by analysts who are employed by Daiwa Securities Group Inc. and/or its non-U.S. affiliates. Neither Daiwa Securities Group Inc. nor any of its subsidiaries or affiliates, nor
any of the foregoing entities’ respective directors, officers, servants and employees accept any liability whatsoever for any direct or consequential loss arising from any use of this research or its
contents.
The information and opinions contained herein have been compiled or arrived at from sources believed to be reliable. However, neither Daiwa Securities Group Inc. nor any of its subsidiaries or
affiliates, nor any of the foregoing entities’ respective directors, officers, servants and employees make any representation or warranty, express or implied, as to their accuracy or completeness.

6
Giant Manufacturing (9921 TT): 25 May 2023

Expressions of opinion herein are subject to change without notice. The use of any information, forecasts and opinions contai ned in this report shall be at the sole discretion and risk of the user.
Daiwa Securities Group Inc., its subsidiaries and affiliates and their respective directors, officers, servants and employees may have positions and financial interest in securities mentioned in this
research. Daiwa Securities Group Inc. and its subsidiaries and affiliates may from time to time perform investment banking or other services for, or solicit investment banking or other business
from, any entity mentioned in this research. Therefore, investors should be aware of conflict of interest that may affect the objectivity of this research.
United Kingdom
This research report is produced by Daiwa Securities Co. Ltd. and/or its affiliates and is distributed in the European Union, Iceland, Liechtenstein, Norway and Switzerland. Daiwa Capital Markets
Europe Limited is authorised and regulated by The Financial Conduct Authority (“FCA”) and is a member of the London Stock Exchange and Eurex. This publication is intended for investors who
are not Retail Clients in the United Kingdom within the meaning of the Rules of the FCA and should not therefore be distributed to such Retail Clients in the United Kingdom. Should you enter into
investment business with Daiwa Capital Markets Europe’s affiliates outside the United Kingdom, we are obliged to advise that the protection afforded by the United Kingdom regulatory system
may not apply; in particular, the benefits of the Financial Services Compensation Scheme may not be available.
Daiwa Capital Markets Europe Limited has in place organisational arrangements for the prevention and avoidance of conflicts of interest. Our conflict management policy is available at
http://www.uk.daiwacm.com/about-us/corporate-governance-regulatory.
Germany
Research reports are produced by Daiwa Securities Co. Ltd. and/or its affiliates and are distributed by Daiwa Capital Markets Deutschland GmbH in the European Union. Daiwa Capital Markets
Deutschland GmbH is authorised and regulated by Bundesanstalt für Finanzdienstleistungsaufsicht (“BaFin“) under the reference number 149361. Daiwa Capital Markets Deutschland GmbH and
its affiliates may, from time to time, to the extent permitted by law, participate or invest in, or be mandated in respect of, other financing transactions with the issuer(s) of the securities referred to
herein (the “Securities”), perform services for or solicit business from such issuers, and/or have a position or effect transactions in the Securities or options thereof.
This publication is intended for investors who are Professional Clients or Eligible Counterparties in the European Union within the meaning of Directive 2014/65/EU (“MiFID II”) and should therefore
not be distributed to Retail Clients in the European Union.
Daiwa Capital Markets Deutschland GmbH has in place organisational arrangements for the identification, prevention and management of conflicts of interest. Information regarding our conflict
management are available at: https://www.de.daiwacm.com/policies/
Additional disclosures regarding specific company names and related financial instruments are available at: https://daiwa3.bluematrix.com/sellside/Disclosures.action.
Bahrain
This research material is distributed in Bahrain by Daiwa Capital Markets Europe Limited, Bahrain Branch, regulated by The Central Bank of Bahrain and holds Investment Business Firm – Category
2 license and having its official place of business at the Bahrain World Trade Centre, South Tower, 7th floor, P.O. Box 30069, Manama, Kingdom of Bahrain. Tel No. +973 17534452 Fax No. +973
535113
United States
This research is distributed into the United States directly by Daiwa Capital Markets Hong Kong Limited (DCMHK) and in certain cases indirectly by Daiwa Capital Markets America Inc. (DCMA),
a U.S. Securities and Exchange Commission registered broker-dealer and FINRA member firm, exclusively to “major U.S. institutional investors”, as defined under Rule 15a-6 promulgated under
the U.S. Securities Exchange Act of 1934, as amended, and as interpreted by the staff of the U.S. Securities and Exchange Commission (SEC). Where this is co-branded research published by
Daiwa’s partners in collaboration with other parties not affiliated with Daiwa, this research is distributed in the United States by DCMHK only. This report is not an offer to sell or the solicitation of
any offer to buy securities. U.S. customers wishing to effect transactions in any designated investment discussed in this report should do so through a qualified salesperson of DCMA. Non-U.S.
customers wishing to effect transactions in any designated investment discussed in this report should contact a Daiwa entity in their local jurisdiction. The securities or other investment products
discussed in this report may not be eligible for sale in some jurisdictions.
Analysts employed outside the U.S., as specifically indicated elsewhere in this report, are not registered as research analysts with FINRA. These analysts may not be associated persons of DCMA,
and therefore may not be subject to FINRA Rule 2241 restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account.
ADDITIONAL IMPORTANT DISCLOSURES CAN BE FOUND AT:
https://daiwa3.bluematrix.com/sellside/Disclosures.action
Ownership of Securities
For “Ownership of Securities” information please visit BlueMatrix disclosure link at https://daiwa3.bluematrix.com/sellside/Disclosures.action.
Investment Banking Relationships
For “Investment Banking Relationships” please visit BlueMatrix disclosure link at https://daiwa3.bluematrix.com/sellside/Disclosures.action.
DCMA Market Making
For “DCMA Market Making” please visit BlueMatrix disclosure link at https://daiwa3.bluematrix.com/sellside/Disclosures.action.
Research Analyst Conflicts
For updates on “Research Analyst Conflicts” please visit BlueMatrix disclosure link at https://daiwa3.bluematrix.com/sellside/Disclosures.action. The principal research analysts who prepared this
report have no financial interest in securities of the issuers covered in the report, are not (nor are any members of their household) an officer, director or advisory board member of the issuer(s)
covered in the report, and are not aware of any material relevant conflict of interest involving the analyst or DCMA, and did not receive any compensation from the issuer during the past 12 months
except as noted: no exceptions.
Research Analyst Certification
For updates on “Research Analyst Certification” and “Rating System” please visit BlueMatrix disclosure link at https://daiwa3.bluematrix.com/sellside/Disclosures.action. The views about any and
all of the subject securities and issuers expressed in this Research Report accurately reflect the personal views of the research analyst(s) primarily responsible for this report (or the views of the
firm producing the report if no individual analyst is named on the report); and no part of the compensation of such analyst (or no part of the compensation of the firm if no individual analyst is named
on the report) was, is, or will be directly or indirectly related to the specific recommendations or views contained in this Research Report.
The following explains the rating system in the report as compared to relevant local indices, unless otherwise stated, based on the beliefs of the author of the report.
"1": the security could outperform the local index by more than 15% over the next 12 months.
"2": the security is expected to outperform the local index by 5-15% over the next 12 months.
"3": the security is expected to perform within 5% of the local index (better or worse) over the next 12 months.
"4": the security is expected to underperform the local index by 5-15% over the next 12 months.
"5": the security could underperform the local index by more than 15% over the next 12 months.

Disclosure of investment ratings


Rating Percentage of total
Buy* 78.27%
Hold** 17.72%
Sell*** 4.01%
Source: Daiwa
Notes: data is for single-branded Daiwa research in Asia (ex Japan) and correct as of 31 March 2023.
* comprised of Daiwa’s Buy and Outperform ratings.
** comprised of Daiwa’s Hold ratings.
*** comprised of Daiwa’s Underperform and Sell ratings.
Additional information may be available upon request.
Japan - additional notification items pursuant to Article 37 of the Financial Instruments and Exchange Law
(This Notification is only applicable where report is distributed by Daiwa Securities Co. Ltd.)
If you decide to enter into a business arrangement with us based on the information described in materials presented along wi th this document, we ask you to pay close attention to the following
items.
 In addition to the purchase price of a financial instrument, we will collect a trading commission* for each transaction as agreed beforehand with you. Since commissions may be included in the
purchase price or may not be charged for certain transactions, we recommend that you confirm the commission for each transaction.
 In some cases, we may also charge a maximum of ¥ 2 million (including tax) per year as a standing proxy fee for our deposit of your securities, if you are a non-resident of Japan.
 For derivative and margin transactions etc., we may require collateral or margin requirements in accordance with an agreement made beforehand with you. Ordinarily in such cases, the amount
of the transaction will be in excess of the required collateral or margin requirements.
 There is a risk that you will incur losses on your transactions due to changes in the market price of financial instruments based on fluctuations in interest rates, exchange rates, stock prices,
real estate prices, commodity prices, and others. In addition, depending on the content of the transaction, the loss could exceed the amount of the collateral or margin requirements.
 There may be a difference between bid price etc. and ask price etc. of OTC derivatives handled by us.
 Before engaging in any trading, please thoroughly confirm accounting and tax treatments regarding your trading in financial instruments with such experts as certified public accountants.
*The amount of the trading commission cannot be stated here in advance because it will be determined between our company and you based on current market conditions and the content of
each transaction etc.

7
Giant Manufacturing (9921 TT): 25 May 2023

When making an actual transaction, please be sure to carefully read the materials presented to you prior to the execution of agreement, and to take responsibility for your own decisions regarding
the signing of the agreement with us.
Corporate Name: Daiwa Securities Co. Ltd.
Financial instruments firm: chief of Kanto Local Finance Bureau (Kin-sho) No.108
Memberships: Japan Securities Dealers Association, The Financial Futures Association of Japan,
Japan Securities Investment Advisers Association, Type II Financial Instruments Firms Association,
Japan Security Token Offering Association

You might also like